A comprehensive view of Drug Delivery / Ingestion. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca licenses global rights to potential gastric cancer treatment CMG901 from KYM Biosciences for US$1.1B; the injectable drug, currently in a Phase I trial, targets Claudin 18.2-positive solid tumors
Published: March 31, 2023 by Marketline - Deals
An Italian study of patients accustomed to self-injecting drugs found that current procedures raise risk of error and contamination; issues included complex preparation procedures, difficulty drawing drug into syringe from vial, risk in use of the needle
Published: March 28, 2023 by Bormioli Pharma SpA
Bristol Myers Squibb receives European Commission approval of Sotyktu deucravacitinib oral treatment for adults with moderate-to-severe plaque psoriasis; psoriasis affects about 14 million people in Europe, with 25% having moderate-to-severe cases
Published: March 28, 2023 by Bristol-Myers Squibb Co.
Cowen predicts global market for weight-loss therapies will be worth US$30B by 2030, and some estimate this market could reach US$50B; with weight-loss drug Wegovy and Ozempic, Novo Nordisk surpasses Nestlé to become Europe's second-largest company
Published: March 24, 2023 by CE Noticias Financieras (Latin America)
Ascend Labs recalls 10 lots of dabigatran etexilate anticoagulant capsules in US after routine test finds suspected carcinogen N-nitroso-dabigatran; products shipped between June 2022 and October 2022
Published: March 23, 2023 by FiercePharma

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count